Article Text

Download PDFPDF
Archivist
Peanut immunotherapy: still working after four years

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Peanut allergy probably causes more disruption and anxiety than any other, at least in the West, perhaps because of its propensity to cause anaphylaxis and its tendency to be lifelong. In April 2014, Archivist reported the successful outcome of the STOP II trial, where continued exposure to small but increasing amounts of ingested peanut protein effectively induced tolerance (doi.org/10.1136/archdischild-2014-306139). But the question remained: how long will this tolerance last?

Now a different trial of peanut tolerance induction through exposure has reported …

View Full Text

Footnotes

  • Handling editor Martin Ward Platt

  • Provenance and peer review Commissioned; internally peer reviewed.